2023 Key Dates

2024 Membership Applications Open	13-August-2023
2024 Award Nominations	21-August-2023
2024 Membership Application Deadline	29-September-2023
47th Annual Meeting - Registration Opens	11-September-2023
Abstract Submissions for 47th Annual Meeting Opens	11-September-2023
Research Grant Applications Open	02-October-2023

Thank you for your participation at the
46th Annual Meeting!

We are still working on providing videos for some of the sessions from the 46th Annual Meeting. We will send a follow-up email once they are all uploaded.

Thank You To All Our Sponsors!

Ruby Level

Appelis

Sapphire Level

Gold Level

Silver Level

Topaz Level

About the Macula Society

Founded in 1977, the Macula Society is a forum for new research in retinal vascular and macular diseases. Membership is by application, with acceptance criteria including extensive contribution to retinal literature. The Macula Society recognizes outstanding achievement by its members and others through awards and lectures, and holds an annual meeting open to members, their guests, co-authors, and supporting company representatives.

Please note:

Our email address has changed! Please use

Maculasociety@maculasociety.org

for all future communications!

Member Login

Forgot Login?

Officers (2023-2024)

President

Daniel F. Martin, MD

Executive Secretary and Founder:

Lawrence J. Singerman, MD

President-Elect:

SriniVas R. Sadda, MD

Secretary:

Julia A. Haller, MD
Treasurer:
Judy E. Kim, MD

Committee Chairs

Awards:

Mark W. Johnson, MD

By-Laws:

Adrienne W. Scott, MD

Credentials:

Lloyd P. Aiello, MD, PhD

Endowment Committee:

Paul Sternberg, Jr., MD
Meeting Planning:

Shlomit Schaal, MD, PhD, MHCM

Nominating:

Ivana K. Kim, MD

Program:

David Sarraf, MD

Research:

Mary Elizabeth Hartnett, MD

Website:

Richard F. Spaide, MD

International Membership:

Lihteh Wu, MD

Young Member Representative:

Christina Weng, MD

Past Presidents

Arnall Patz, MD

J. Donald M. Gass, MD

Morton F. Goldberg, MD

Robert C. Watzke, MD

Stephen J. Ryan, MD

John G. Clarkson, MD

David H. Orth, MD

Alexander J. Brucker, MD

Lee M. Jampol, MD

Thomas M. Aaberg, MD

Travis A. Meredith, MD

Kurt A. Gitter, MD

William F. Mieler, MD

Daniel Finkelstein, MD

Lawrence A. Yannuzzi, MD

Evangelos S. Gragoudas, MD

Jerry A. Shields, MD

Michael L. Klein, MD

Emily Y. Chew, MD

Mark S. Blumenkranz, MD

Neil M. Bressler, MD

Paul Sternberg, Jr., MD

M. Gilbert Grand, MD

Andrew P. Schachat, MD

James C. Folk, MD

H. Richard McDonald, MD

Joan W. Miller, MD

Carol L. Shields, MD
Mark W. Johnson, MD
Immediate Past President
Glenn J. Jaffee, MD

Member News

Macula Society Endowment Fund

The Macula Society Educational Endowment provides a revenue stream to fund various educational initiatives in perpetuity, independent of year-to-year fluctuations in corporate support and other society income sources.

Join us for the 6th Biennial Symposium on AMD, taking place on September 29-30, 2023, at the Starr Center at the Schepens Eye Research Institute of Mass Eye and Ear in Boston. The conference aims to highlight the latest innovations in AMD disease research. This event promises in-depth and thoughtful discussions on the pathogenesis of AMD, with national and international experts in various fields, including Omics, Immunity, Oxidative Stress, Aging, Retinal Pigment Epithelium, and In Vitro Models. With 200-250 anticipated attendees, including clinician-scientists, researchers, industry representatives, and trainees, this symposium is the perfect platform for networking and exchanging ideas. The sessions will be moderated by experts in the field and will feature short talks followed by an extended panel discussion. Register now to join this informative and engaging symposium!

Registration Link: https://www.eventleaf.com/e/2023AMD

September 7-9, 2023
Santa Clara, California
Join the Interest List at:
www.APR2023.com

The DRCR Retina Network is planning an exciting new Phase III clinical trial to prevent visual acuity loss due to radiation retinopathy (RR). Eligible participants will be randomized to receive either repeated injections of anti-VEGF, long-active steroid, or observation following treatment of choroidal melanoma with I-125 plaque brachytherapy.

Any interested physicians or clinical sites should contact drcrnet@jaeb.org to learn more about joining the Network.

Conference Management Software by X-CD Technologies Inc.